Lymphopenia and fumaric acid esters for psoriasis: a retrospective case series prompted by the European Medicines Agency's Pharmacovigilance Risk Assessment Committee ( PRAC PRAC ) recommendations

Roche L.; Lynch M.; Ahmad K.; Hackett C.; Ramsay B.

首页> 外文期刊>Clinical and experimental dermatology >Lymphopenia and fumaric acid esters for psoriasis: a retrospective case series prompted by the European Medicines Agency's Pharmacovigilance Risk Assessment Committee ( PRAC PRAC ) recommendations

【24h】

Lymphopenia and fumaric acid esters for psoriasis: a retrospective case series prompted by the European Medicines Agency's Pharmacovigilance Risk Assessment Committee ( PRAC PRAC ) recommendations

机译：淋巴细胞和牛皮癣的富马酸酯：欧洲药物局的药物知识风险评估委员会（PRAC PRAC）建议提示了一种回顾性案例系列

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical and experimental dermatology 》 |2018年第1期| 共4页
作者
Roche L.; Lynch M.; Ahmad K.; Hackett C.; Ramsay B.;
展开▼
作者单位

Department of DermatologyUniversity Hospital LimerickDooradoyle Limerick Ireland;

Department of DermatologyUniversity Hospital LimerickDooradoyle Limerick Ireland;

Department of DermatologyUniversity Hospital LimerickDooradoyle Limerick Ireland;

Department of DermatologyUniversity Hospital LimerickDooradoyle Limerick Ireland;

Department of DermatologyUniversity Hospital LimerickDooradoyle Limerick Ireland;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类皮肤病学与性病学 ;
关键词

相似文献

外文文献

1. Lymphopenia and fumaric acid esters for psoriasis: a retrospective case series prompted by the European Medicines Agency's Pharmacovigilance Risk Assessment Committee ( PRAC PRAC ) recommendations [J] . Roche L., Lynch M., Ahmad K., Clinical and experimental dermatology . 2018 ,第1期

机译：淋巴细胞和牛皮癣的富马酸酯：欧洲药物局的药物知识风险评估委员会（PRAC PRAC）建议提示了一种回顾性案例系列
2. The European Medicines Agency review of ofatumumab (Arzerra(R)) for the treatment of chronic lymphocytic leukemia in patients refractory to fludarabine and alemtuzumab: summary of the scientific assessment of the European medicines agency committee for medicinal products for human use. [J] . Gravanis I, Ersboll J, Skovlund E, The oncologist . 2010 ,第12期

机译：欧洲药物管理局对ofatumumab（Arzerra（R））在氟达拉滨和阿仑单抗难以治疗的患者中治疗慢性淋巴细胞性白血病的评论：欧洲药物管理局人类使用药品的委员会的科学评估摘要。
3. The European Medicines Agency Review of Ofatumumab (Arzerra?) for the Treatment of Chronic Lymphocytic Leukemia in Patients Refractory to Fludarabine and Alemtuzumab: Summary of the Scientific Assessment of the European Medicines Agency Committee for Medicinal Products for Human Use [J] . Eric Abadie, Eva Skovlund, Francesco Pignatti, The oncologist . 2010 ,第12期

机译：欧洲药物管理局Ofatumumab（Arzerra？）对氟达拉滨和Alemtuzumab难治性患者的慢性淋巴细胞性白血病的治疗回顾：欧洲药物管理局人类使用药物产品委员会的科学评估摘要
4. Impact of the Detection and Quantitation Limits on the Analytical Feasibility of Measuring the European Chemicals Agency Risk Assessment Committee's Recommendations for Occupational Exposure Limit Values for Nickel and Its Compounds in the Workplace [C] . Steven Verpaele Symposium on detection limits in air quality and environmental measurements . 2019

机译：检测和定量限制对测量欧洲化学物质机构风险评估委员会的分析可行性的分析可行性，为镍及其化合物在工作场所的职业暴露限制值
5. Fumaric acid ester‐induced T‐cell lymphopenia in the real‐life treatment of psoriasis [O] . H. Dickel, T. Bruckner, S. Höxtermann, -1

机译：富马酸酯诱导的T细胞淋巴细胞减少症在现实生活中治疗牛皮癣
6. PHP121 Descriptive Review Of The Pharmacovigilance And Risk Assessment Committee (Prac) Activities Since Its Establishment [O] . Acquadro C., Boxall N., Maier W. 2014

机译：自成立以来的药物警戒和风险评估委员会（Prac）活动的PHP121描述性审查

Lymphopenia and fumaric acid esters for psoriasis: a retrospective case series prompted by the European Medicines Agency's Pharmacovigilance Risk Assessment Committee ( PRAC PRAC ) recommendations

著录项

相似文献

相关主题

期刊订阅